TransMedics Group Résultats passés
Passé contrôle des critères 2/6
TransMedics Group a connu une croissance annuelle moyenne de ses bénéfices de 20.5%, tandis que le secteur Medical Equipment a vu ses bénéfices augmenter de en hausse à 12.5% par an. Les revenus ont augmenté de en hausse à un taux moyen de 61.4% par an. Le rendement des capitaux propres de TransMedics Group est 15.5% et ses marges nettes sont de 8.1%.
Informations clés
20.5%
Taux de croissance des bénéfices
35.0%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 8.9% |
| Taux de croissance des recettes | 61.4% |
| Rendement des fonds propres | 15.5% |
| Marge nette | 8.1% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
TransMedics: Overreaction To Temporary Headwinds (Rating Upgrade)
Nov 12What You Can Learn From TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S After Its 44% Share Price Crash
Oct 30
TransMedics: Mistakes Have Been Made, Here's My Updated Outlook
Oct 29TransMedics' Organ Care: Critical Innovation With Lofty Expectations
Oct 23TransMedics Group: This Could Be One Of The Biggest Moats In A Decade
Oct 16Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)
Sep 18TransMedics: Take Profits While The Valuation Is Sky High
Sep 18TransMedics: Wide Moat Player At A Lower Valuation Than Peers
Sep 10TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce
Aug 28TransMedics: Heart And Lungs Will Drive The Next Leg Higher
Aug 19Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts
Aug 06TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy
Aug 04TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 02TransMedics Group Stock: Too Far, Too Fast
Jul 08TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey
Jun 17TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger
Jun 10TransMedics: Transportation Supporting Growth
May 21TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
May 06TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 24TransMedics Group: Founder Led Company With Solid Potential
Apr 19Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
Mar 19TransMedics Group: Huge Opportunity In Organ Transplants
Mar 12TransMedics: A Very Expensive Growth Stock
Feb 07With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For
Jan 23Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Jan 02Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year
Aug 06TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing
Jun 29Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts
May 06Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Apr 09Ventilation des recettes et des dépenses
Comment TransMedics Group gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 401 | 33 | 154 | 50 |
| 30 Jun 24 | 359 | 3 | 142 | 47 |
| 31 Mar 24 | 297 | -10 | 129 | 42 |
| 31 Dec 23 | 242 | -25 | 118 | 36 |
| 30 Sep 23 | 192 | -36 | 107 | 31 |
| 30 Jun 23 | 151 | -18 | 93 | 27 |
| 31 Mar 23 | 119 | -28 | 81 | 25 |
| 31 Dec 22 | 93 | -36 | 70 | 27 |
| 30 Sep 22 | 72 | -42 | 60 | 27 |
| 30 Jun 22 | 51 | -48 | 54 | 26 |
| 31 Mar 22 | 39 | -47 | 45 | 25 |
| 31 Dec 21 | 30 | -44 | 38 | 22 |
| 30 Sep 21 | 28 | -38 | 32 | 21 |
| 30 Jun 21 | 30 | -30 | 28 | 20 |
| 31 Mar 21 | 25 | -28 | 24 | 17 |
| 31 Dec 20 | 26 | -29 | 24 | 19 |
| 30 Sep 20 | 24 | -32 | 24 | 21 |
| 30 Jun 20 | 24 | -35 | 25 | 21 |
| 31 Mar 20 | 26 | -36 | 26 | 22 |
| 28 Dec 19 | 24 | -34 | 24 | 20 |
| 28 Sep 19 | 21 | -32 | 22 | 17 |
| 29 Jun 19 | 18 | -29 | 18 | 15 |
| 30 Mar 19 | 15 | -26 | 15 | 14 |
| 29 Dec 18 | 13 | -24 | 12 | 14 |
| 29 Sep 18 | 12 | -21 | 10 | 14 |
| 30 Jun 18 | 9 | -20 | 9 | 14 |
| 31 Mar 18 | 8 | -20 | 8 | 14 |
| 30 Dec 17 | 8 | -21 | 8 | 15 |
| 31 Dec 16 | 6 | -24 | 8 | 16 |
Des revenus de qualité: TMDX a un niveau élevé de bénéfices non monétaires.
Augmentation de la marge bénéficiaire: TMDX est devenu rentable dans le passé.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: TMDX est devenue rentable au cours des 5 dernières années, augmentant ses bénéfices de 20.5% par an.
Accélération de la croissance: TMDX est devenu rentable au cours de l'année dernière, ce qui rend le taux de croissance des bénéfices difficile à comparer à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: TMDX est devenue rentable au cours de l'année dernière, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Medical Equipment ( 11.7% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de TMDX ( 15.5% ) est considéré comme faible.